Stem Cell Banking Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Oct 2023

Pages: 156

SKU: IRTNTR71861

Snapshot

Stem Cell Banking Market Forecast 2024-2028

The global stem cell banking market size is estimated to grow by USD 8.23 billion at a CAGR of 11.65% between 2023 and 2027. The market growth is fueled by the escalating demand for personalized medicines, coupled with advancements in regenerative medicine. Personalized banking applications facilitate tailored treatments, aligning with individual patient characteristics and preferences. Stem cell-based research, especially in hematopoietic stem cell transplantations, holds promise for addressing neurodegenerative and cardiovascular conditions. Tissue banks and biobanks play a pivotal role in storing adult tissues and stem cells, both used and unused, for clinical applications.

Cryogenically freezing enables long-term preservation of stem cells for future therapies. Progress in regenerative medicine, including IPS cells, offers hope for conditions previously deemed untreatable. Despite initial costs, market research and growth analysis project a promising market forecast, emphasizing the importance of continued innovation and investment in personalized healthcare solutions..

Market Share

For More Highlights About this Report, Download Free Sample in a Minute

Market Segmentations

Product Type Segment

The market share growth by the adult stem cells segment will be significant during the forecast period. Adult stem-cells are found in developed tissues such as the heart, brain, and kidney, where they mature and repair damaged tissues through cell division. They are abundant in infants, children, and adults. The adult stem-cell banking segment leads the market owing to the easy availability of these cells within the human body.

Get a glance at the market contribution of various segments Download the PDF Sample

The adult stem cells segment was valued at USD 4.08 billion in 2018. Furthermore, HLA typing is used to match patients and donors before bone marrow or blood transplants. Moreover, it is important during adult stem-cell transplantation, as the donor cells can adversely affect the recipient's immune system, leading to autoimmune disorders owing to HLA incompatibility.

However, easy extraction procedures and the vast availability of these cells are likely to support the demand for adult stem-cell banking and ensure the growth of this segment, which will thereby drive the growth of the global market during the forecast period.

Regional Analysis

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

North America is the largest revenue contributor to the global market due to the state-of-the-art technological support and the growing presence of established market players that provide stem-cell storage and processing services and use stem-cells for developing treatments for diseases such as cancer.

Moreover, the US and Canada are the highest revenue contributors in the region due to several factors, such as the presence of a well-developed healthcare system, which lets market players providing biotechnology solutions such as stem-cell banking easily establish themselves in the market. Furthermore, personalized medicines through stem-cell therapy have many benefits that are essential for the future of personal health. Hence, such factors will drive the demand for stem-cell banking, thereby driving the regional market during the forecast period.

Market Dynamics and Customer Landscape

The market is witnessing significant growth, propelled by the surge in demand for personalized medicines and the increasing focus on regenerative medicines. Stem cell banking offers personalized banking applications with various sources such as placental stem cells, embryonic stem cells, bone marrow stem cells, and adipose tissue stem cells, catering to diverse therapeutic needs. A notable trend in this market is the growing interest in stem cell-based research and its therapeutic potential in treating various medical conditions.

However, amidst this growth, challenges persist, particularly concerning ethical concerns in stem cell research, which necessitate stringent regulatory frameworks and public awareness initiatives. Overcoming these challenges is crucial for ensuring the sample preservation integrity and sustainability of tissue banks and biobanks, ultimately driving market growth analysis and market forecasting in this sector.

Key Market Driver

The surge in demand for tailored medications is the primary driver of market expansion. Personalized medicines cater to patients' unique characteristics, needs, and preferences. Consequently, research institutions are actively exploring avenues to create customized therapies, focusing on utilizing mesenchymal stem cells due to their numerous advantages. These advantages encompass reduced risk of immune rejection, elimination of the necessity for embryonic stem cells, decreased reliance on anti-rejection medications, lower probability of graft rejection, and diminished likelihood of developing graft-versus-host disease (GvHD). Stem cell isolation techniques play a crucial role in this endeavor. Market analysis indicates a promising outlook for growth, with forecasts highlighting the significance of leveraging used and unused stem cells to address neurodegenerative conditions and the implications of delayed parenthood on healthcare needs.

Furthermore, mesenchymal stem cells (MSCs) that are present in the vascular region of the bone marrow serve as the cellular support of the hematopoietic stem cells (HSCs). In addition, the MSC also possesses some immunosuppressive properties that are beneficial for Hematopoietic stem cell transplantation (HSCT) and for the treatment of inflammatory and autoimmune diseases. Thus, the use of MSC during HSCT has improved the engraftment rate of hematopoietic stem-cells by reducing the GvDH. Hence, such factors will drive the growth of the market during the forecast period.

Significant Market Trends

The rising focus on regenerative medicines is the primary trend shaping market growth. Regenerative medicine is evolving as a buzzword in the medical community. Since the human body is capable of self-healing, regenerative therapies have the potential to treat rare diseases effectively. Regenerative medicine is a method to regrow, repair, or replace damaged or diseased cells, organs, or tissues. It contains stem-cell therapy and platelet-rich plasma (PRP) therapy.

In addition, the research around these therapies is increasing every day. They enhance cell-to-cell communication, which is essential for overall cell health. Thus, the rising trend of regenerative therapies will drive the demand for stem-cell banking, thereby driving the growth of the global market during the forecast period.

Major Market Challenge

Ethical concerns in stem cell research is a challenge that affects market growth. Scientists and policymakers encounter ethical issues with stem-cell development. Several issues include the cloning of embryonic stem-cells and the destruction of sources to create cell lines. Issues regarding safety, scientific purity, and consent for the use of human embryonic stem-cell lines for research purposes have always been a major concern. Federal laws and state policies in terms of secondary usage of genetic information are highly irregular, especially in countries such as the US, which has the biggest market for gene therapy in terms of revenue.

Furthermore, proper infrastructure and recommendations should be established for the collection and usage of stem-cells to alleviate the uncertainty that acts as a hindrance to the donation of stem-cells. The lack of stem-cell donations will prevent advances in treatments and adversely impact the need to preserve stem-cells, consequently impeding the growth of the global market report during the forecast period.

Key Companies in Market

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Cordlife Group Ltd.: The company offers products which allows a parent to preserve their child's stem-cells present in the umbilical cord blood and used in treating various life-threatening disorders.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is witnessing remarkable growth due to public awareness and the therapeutic potential of stem-cells in treating various conditions. With heavy investments by private companies and government support, the market is advancing rapidly, especially in developed nations.

Stem cells sourced from various tissues such as placental stem cells, bone marrow stem cells, and adipose tissue stem-cells hold immense regenerative potential, offering hope for conditions like leukemia, diabetes, and neurodegenerative disorders. Cryopreservation techniques ensure the viability and accessibility of these cells for future use.

The umbilical cord blood banking sector plays a crucial role in sample preservation and storage, employing advanced transportation technologies for safe sample collection and transportation. Both private stem cell banks and public stem cell banks contribute to sample analysis for research applications and clinical trials.

Regulatory frameworks govern the licensing approval process, ensuring the safety and efficacy of stem cell therapies. As the aging population grows, stem-cell banking addresses the rising prevalence of chronic diseases such as osteoarthritis and cardiovascular diseases. The future of the market looks promising, driven by ongoing medical advancements and market growth and forecasting.

Market Scope
Report Coverage	Details
Page number	156
Base year	2023
Historic period	2018 - 2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 11.65%
Market growth 2024-2028	USD 8.23 billion
Market structure	Fragmented
YoY growth 2023-2024(%)	9.95
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 41%
Key countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	AMS Biotechnology Europe Ltd., CellSave Arabia FZ LLC, Cordlife Group Ltd., CordVida, Cryo Cell International Inc., Cryo Stemcell, Cryoviva Biotech Pvt. Ltd., FUJIFILM Corp., Global Cord Blood Corp., Kids Clinic India Pvt. Ltd., LifeCell International Pvt. Ltd., MEDIPOST Co. Ltd., New England Cord Blood Bank Inc., PerkinElmer Inc., Plus Therapeutics Inc., ReeLabs Pvt. Ltd., Regenerative Medical Services Pvt. Ltd., Smart Cells International Ltd., StemCyte India Therapeutics Pvt. Ltd., and Vita 34 International AG
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download PDF Sample

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market between 2024 and 2028
Precise estimation of the size of the market size and its contribution of the market in focus to the parent market
Accurate predictions about upcoming trends and changes in consumer behaviour
Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
Thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements.

Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global stem cell banking market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global stem cell banking market 2018 - 2022 ($ billion)

4.2 Product Type Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Type Segment 2018 - 2022 ($ billion)

4.3 Type Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Type Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product Type

6.1 Market segments
- Exhibit 30: Chart on Product Type - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product Type - Market share 2023-2028 (%)

6.2 Comparison by Product Type
- Exhibit 32: Chart on Comparison by Product Type
- Exhibit 33: Data Table on Comparison by Product Type

6.3 Adult stem cells - Market size and forecast 2023-2028
- Exhibit 34: Chart on Adult stem cells - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Adult stem cells - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Adult stem cells - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Adult stem cells - Year-over-year growth 2023-2028 (%)

6.4 Umbilical cord blood stem cells - Market size and forecast 2023-2028
- Exhibit 38: Chart on Umbilical cord blood stem cells - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Umbilical cord blood stem cells - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Umbilical cord blood stem cells - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Umbilical cord blood stem cells - Year-over-year growth 2023-2028 (%)

6.5 Embryonic stem cells - Market size and forecast 2023-2028
- Exhibit 42: Chart on Embryonic stem cells - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Embryonic stem cells - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Embryonic stem cells - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Embryonic stem cells - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by Product Type
- Exhibit 46: Market opportunity by Product Type ($ billion)
- Exhibit 47: Data Table on Market opportunity by Product Type ($ billion)

7 Market Segmentation by Type

7.1 Market segments
- Exhibit 48: Chart on Type - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Type - Market share 2023-2028 (%)

7.2 Comparison by Type
- Exhibit 50: Chart on Comparison by Type
- Exhibit 51: Data Table on Comparison by Type

7.3 Private - Market size and forecast 2023-2028
- Exhibit 52: Chart on Private - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on Private - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on Private - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Private - Year-over-year growth 2023-2028 (%)

7.4 Public - Market size and forecast 2023-2028
- Exhibit 56: Chart on Public - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on Public - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on Public - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Public - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Type
- Exhibit 60: Market opportunity by Type ($ billion)
- Exhibit 61: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Canada - Market size and forecast 2023-2028
- Exhibit 87: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 China - Market size and forecast 2023-2028
- Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ billion)
- Exhibit 104: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 Cordlife Group Ltd.
- Exhibit 111: Cordlife Group Ltd. - Overview
- Exhibit 112: Cordlife Group Ltd. - Business segments
- Exhibit 113: Cordlife Group Ltd. - Key offerings
- Exhibit 114: Cordlife Group Ltd. - Segment focus

12.4 CordVida
- Exhibit 115: CordVida - Overview
- Exhibit 116: CordVida - Product / Service
- Exhibit 117: CordVida - Key offerings

12.5 Cryo Cell International Inc.
- Exhibit 118: Cryo Cell International Inc. - Overview
- Exhibit 119: Cryo Cell International Inc. - Business segments
- Exhibit 120: Cryo Cell International Inc. - Key offerings
- Exhibit 121: Cryo Cell International Inc. - Segment focus

12.6 Cryo Stemcell
- Exhibit 122: Cryo Stemcell - Overview
- Exhibit 123: Cryo Stemcell - Product / Service
- Exhibit 124: Cryo Stemcell - Key offerings

12.7 Cryoviva Biotech Pvt. Ltd.
- Exhibit 125: Cryoviva Biotech Pvt. Ltd. - Overview
- Exhibit 126: Cryoviva Biotech Pvt. Ltd. - Product / Service
- Exhibit 127: Cryoviva Biotech Pvt. Ltd. - Key offerings

12.8 FUJIFILM Corp.
- Exhibit 128: FUJIFILM Corp. - Overview
- Exhibit 129: FUJIFILM Corp. - Business segments
- Exhibit 130: FUJIFILM Corp. - Key news
- Exhibit 131: FUJIFILM Corp. - Key offerings
- Exhibit 132: FUJIFILM Corp. - Segment focus

12.9 Global Cord Blood Corp.
- Exhibit 133: Global Cord Blood Corp. - Overview
- Exhibit 134: Global Cord Blood Corp. - Product / Service
- Exhibit 135: Global Cord Blood Corp. - Key offerings

12.10 Kids Clinic India Pvt. Ltd.
- Exhibit 136: Kids Clinic India Pvt. Ltd. - Overview
- Exhibit 137: Kids Clinic India Pvt. Ltd. - Product / Service
- Exhibit 138: Kids Clinic India Pvt. Ltd. - Key offerings

12.11 LifeCell International Pvt. Ltd.
- Exhibit 139: LifeCell International Pvt. Ltd. - Overview
- Exhibit 140: LifeCell International Pvt. Ltd. - Product / Service
- Exhibit 141: LifeCell International Pvt. Ltd. - Key offerings

12.12 PerkinElmer Inc.
- Exhibit 142: PerkinElmer Inc. - Overview
- Exhibit 143: PerkinElmer Inc. - Business segments
- Exhibit 144: PerkinElmer Inc. - Key news
- Exhibit 145: PerkinElmer Inc. - Key offerings
- Exhibit 146: PerkinElmer Inc. - Segment focus

12.13 Plus Therapeutics Inc.
- Exhibit 147: Plus Therapeutics Inc. - Overview
- Exhibit 148: Plus Therapeutics Inc. - Product / Service
- Exhibit 149: Plus Therapeutics Inc. - Key offerings

12.14 ReeLabs Pvt. Ltd.
- Exhibit 150: ReeLabs Pvt. Ltd. - Overview
- Exhibit 151: ReeLabs Pvt. Ltd. - Product / Service
- Exhibit 152: ReeLabs Pvt. Ltd. - Key offerings

12.15 Regenerative Medical Services Pvt. Ltd.
- Exhibit 153: Regenerative Medical Services Pvt. Ltd. - Overview
- Exhibit 154: Regenerative Medical Services Pvt. Ltd. - Product / Service
- Exhibit 155: Regenerative Medical Services Pvt. Ltd. - Key offerings

12.16 Smart Cells International Ltd.
- Exhibit 156: Smart Cells International Ltd. - Overview
- Exhibit 157: Smart Cells International Ltd. - Product / Service
- Exhibit 158: Smart Cells International Ltd. - Key offerings

12.17 StemCyte India Therapeutics Pvt. Ltd.
- Exhibit 159: StemCyte India Therapeutics Pvt. Ltd. - Overview
- Exhibit 160: StemCyte India Therapeutics Pvt. Ltd. - Product / Service
- Exhibit 161: StemCyte India Therapeutics Pvt. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 162: Inclusions checklist
- Exhibit 163: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 164: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 165: Research methodology
- Exhibit 166: Validation techniques employed for market sizing
- Exhibit 167: Information sources

13.5 List of abbreviations
- Exhibit 168: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

stem cell banking market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis